CORONA Remedies shareholding pattern

·Pharma & HealthChart ›

Who owns itSep 2026 quarter

Promoters69.00%no change
Foreign investors (FII)4.21%+0.58 pts
Domestic institutions (DII)16.45%+3.55 pts
of which mutual funds16.06%+3.56 pts
of which insurance companies0.25%
Public10.34%

Per cent of all shares; change on the Jun 2026 quarter, in percentage points. As filed with the exchanges.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

CORONA₹2,050.00

CORONA Remedies Ltd.

· Pharma & Health
₹ CrorePeersERISMANKINDAPLLTDALIVUSAKUMSAGARWALEYEHCGADVENZYMESMcap ₹12,538 Cr
Holding % of Total Shares
12 Months Ending
Q3 FY26
13/12/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Q2 FY27
30/09/2026
Promoter & Group69.0069.0069.0069.0069.00
FII / FPI1.041.842.253.634.21
DII3.656.767.0212.9016.45
Mutual Funds2.446.386.3512.5016.06
Latest: 2026-09-30 · 5 quarters of history · click a row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.